期刊文献+

非ST段抬高急性冠脉综合征患者30天内发生急性心血管事件的危险因素探讨 被引量:2

Major risk factors of patients thirty days with non-ST elevation acute coronary syndrome
下载PDF
导出
摘要 目的 分析预测非ST段抬高急性冠状动脉综合征(ACS)患者30天内发生心血管事件的独立危险因素。方法 根据283例非ST段抬高ACS患者就诊即刻的临床情况、心电图变化和心肌生化标志物水平,判断预测30天内急性心血管事件的独立危险因素;急性心血管事件的定义为死亡、恶性室性心律失常、再发心肌梗死和心绞痛、急性左心功能衰竭、需重复经皮冠状动脉成形术(PTCA)或冠状动脉旁路移植术(CABG)或再次住院。结果 共33例患者(11.7%)发生急性心血管事件;多因素分析发现30天内心血管事件的独立预测因素包括高龄(OR=1.39,95%CI 1.13~1.82,P=0.006)、糖尿病史(OR=2.21,95%CI 1.29~3.79,P=0.013)、就诊时心电图ST段压低(OR=2.49,95%CI 1.26~3.98,P=0.004)、就诊12小时内心肌生化标志物阳性(OR=2.84,95%CI 1.42~5.38,P=0.003)。结论 年龄增加、糖尿病、就诊即刻心电图ST段压低和就诊12小时以内心肌特异性酶学改变(CK-MB或TNT)4项因素是非ST段抬高ACS患者在30天内发生急性心血管事件的独立预测因素。 Objective To determine the independent factors of major adverse cardiovascular events (MACE) within 30 days of presentation in patients with non-ST elevation acute coronary syndrome (ACS). Methods This was a prospectively designed cohort study including 283 patients with unstable angina pectoris or non-ST elevations ACS.The data of presentation and the MACE were recorded within 30 days of follow-up. Death, malignant ventricular arythmia, acute heart failure, revascularization and rehospitalization were defined as MACE. Results MACE took place in 33 patients ((11.7)%). Multiple logistic regression analysis identified four presenting clinical factors predicted the 30-day MACE:① age[odds ratio(OR),(1.39); 95% confidence interval(CI), (1.13)-(1.82),P=(0.006))]; ② diabetes (OR, (2.21); 95%CI, (1.29)-(3.79),P=(0.013)); ③ baseline ST depression(OR, (2.49); 95%CI, (1.26)-(3.98),P=(0.004)); ④ myocardial enzymes positive within 12 hours of presentation (OR, (2.84); 95% CI, (1.42)-(5.38), P=(0.003)). Conclusion The prospectively designed cohort study identified age, diabetes, baseline ST depression, myocardial enzymes positive within 12 hours of presentation are the predictors of MACE within 30 day of presentation.
出处 《临床荟萃》 CAS 北大核心 2005年第16期901-904,共4页 Clinical Focus
关键词 冠状动脉疾病 心电描记术 因素分析 统计学 随访研究 coronary disease electrocardiography factor analysis,statistical follow-up studies
  • 相关文献

参考文献8

  • 1YAN A T, JONG P, YAN R T, et al. Clinical trial-derived risk model may not generalize to real-world patients with acute coronary syndrome[J]. Am Heart J, 2004,148(6): 1020-1027.
  • 2BRAUNWALD E, ANTMAN E M, BEASLEY J W, et al.ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article[J]. J Am Coil Cardiol,2002, 40(7) :1366-1374.
  • 3de ARAUJO GONCALVES P, FERREIRA J, AGUIAR C, et al. TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTEACS[J]. Eur Heart J, 2005, 26(9) :865-872.
  • 4EAGLE K A, LIM M J, DABBOUS O H, et al. A validated prediction model for all forms of acute coronary syndrome:estimating the risk of 6-month postdischarge death in an international registry[J]. JAMA, 2004,291(22) :2727-2733.
  • 5GRANGER C B, GOLDBERG R J, DABBOUS O, et al.Predictors of hospital mortality in the global registry of acute coronary events[J]. Arch Intern Med, 2003, 163 (19): 2345-2353.
  • 6王建旗.非ST段抬高急性冠脉综合征危险分层模式回顾[J].中国医药导刊,2003,5(4):269-272. 被引量:1
  • 7CANNON C P, WEINTRAUB W S, DEMOPOULOS L A, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein Ⅱb/Ⅲa inhibitor tirofiban[J]. N Engl J Med,2001, 344(25) :1879-1887.
  • 8MORROW D A, CANNON C P, FIFAI N, et al. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and nonST elevation myocardial infarction: results from a randomized trial[J]. JAMA, 2001, 286(19):2405-2412.

二级参考文献25

  • 1Marrow DA, Antman EM, Tanasijevic M, et al. Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: aTIMI- 11B substudy. J Am Coll Cardiol, 2000;36:1812- 1817.
  • 2Fragmin and Fast Revascularization During Instability in Coronary Artery Disease Investigators: Invasive compared with non - invasive treatment in unstable coronary artery disease: FRISC II prospective randomized multicenter study. Lancet, 1999;354:701 - 707.
  • 3Cannon CP, Weintraub WS, Demopoulos LA, et al. TACTICS-Thrombolysis in Myocardial Infarction(TIMI)18 Investigators: Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein Ⅱb/ Ⅲa inhibitor tirofiban.N Engl J Med, 2001;344: 1879- 1887.
  • 4Antman EM, Cohen M, Bernink PJL, et al. The TIMI risk score for unstable angina/ non - ST - elevation MI : a method for prognostic and therapeutic decision miking. JAMA,2000;284:835 - 842.
  • 5Cohen M, Demers C, Gurfinkel EP, et al. The efficacy and safety of subcutaneous enoxaparin in non - Q - wave coronary events(ESSENCE)study group: A comparison of low molecular weight heparin with unfractionated heparin for unstable coronary artery disease. N Engl J Med, 1997;337:447 - 452.
  • 6Morrow DA, Antman EM, Snapinn SM, et al. An integrated clinical approach to predicting the benefit of tirofiban in non - ST - elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM - PLUS. Eur Heart J, 2002;23:223- 229.
  • 7Predictors of Outcome in Patients With Acute Coronary Syndrome Without Persistent ST- Segment Elevation- Results From an International Trial of 9461 Patients. Circulation, 2000;101:2557- 2567.
  • 8ACC/AHA 2002 Guideline Update for the Management of Patients With Unstable Angina and Non- ST- Segment Elevation Myocardial Infarction - Summary Article. J Am Coil Cardiol, 2002;407:1366 - 1374.
  • 9Jernberg T, Lindahl B, Wallentine L. The combination of a continuous 12- lead ECG and troponin T. A valuable tool for risk stratification during the first 6 hours in patients with chest pain and nondiagnostic ECG. Eur Heart J, 2000;21 : 1464 - 1472.
  • 10Lindahl B, Toss H, Siegbahn A, et al. Markers of myocardial damage and inflammation in relation to long - term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during instability in coronary artery disease. N Engl J Med, 2000;343:1139- 1147.

同被引文献19

  • 1衣玉军.急性心肌梗死院前溶栓治疗12例分析[J].中国全科医学,2005,8(3):225-225. 被引量:7
  • 2郭爱桃,韦立新,石怀银,童新元,游联璧,王士雯.冠状动脉粥样硬化斑块破裂的临床危险因素分析[J].中华老年心脑血管病杂志,2000,2(1):15-17. 被引量:9
  • 3张高峰,许澎,伍旭升,乔祺.年龄对急性冠状动脉综合征患者冠状动脉介入治疗预后的影响[J].中华老年医学杂志,2005,24(2):115-116. 被引量:4
  • 4柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2117
  • 5[2]秦任甲.临床细胞流变学[M].北京:北京大学医学出版社,2006:156-158.
  • 6Takahashi T,Hiasa Y,Ohara Y,et al.Relation between neutrophil counts on admission,microvascular injury,and left ventricular functional recovery in patients with an anterior wall first acute myocardial infarction treated with primary coronary angioplasty.Am J Cardiol,2007,100:35-40.
  • 7Gurm HS,Bhatt DL,Lincoff AM,et al.Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention:insights from the EPIC,EPILOG,and EPISTENT trials.Heart,2003,89:1200-1204.
  • 8Critchley JA,Capewell S.Mortality risk reduction associated with smoking cessation in patients with coronary heart disease:a systematic review.JAMA,2003,290:86-97.
  • 9Ross R,Glomset JA.Atherosclerosis and the arterial smooth muscle cell proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis.Science,1973,180:1332-1339.
  • 10Núez JE,Núez E,Bertomeu V,et al.Prognostic value of baseline white blood cell count in patients with acute myocardial infarction and ST segment elevation.Heart,2005,91:1094-1095.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部